Cardiovascular & Hematological Disorders-Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in cardiovascular and hematological disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal contains a series of in-depth/mini reviews, original research articles, drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics on drug targets involved in cardiovascular and hematological disorders. As the discovery, identification, characterization and validation of novel human drug targets for cardiovascular and hematological drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.
Pietro Scicchitano Cardiology Department Hospital "F. Perinei" Altamura (BA) Bari (Italy) Biography
Biography of Pietro Scicchitano
Dr. Scicchitano Pietro completed his degree in Medicine and Surgery with maximum votes, discussing a thesis entitled “Evaluation of cardiovascular risk in patients suffering from Polycystic Ovary Syndrome”. He completed his Ph.D. in Biomolecular, Pharmacological and Medical Science from the Department of Oncology, University of Bari, Italy. He is a member of the directive nucleo of Hypertension, Prevention and Rehabilitation Group of Italian Society of Cardiology. Dr. Pietro is the author of 130 articles in International Scientific Journals, with 250 abstracts published in International Journals and 4 chapters of scientific books.